King Luther Capital Management Corp Pfizer Inc Transaction History

King Luther Capital Management Corp

$21.9 Billion
Q1 2024

A detailed history of King Luther Capital Management Corp transactions in Pfizer Inc stock. As of the latest transaction made, King Luther Capital Management Corp holds 2,149,345 shares of PFE stock, worth $60.2 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

2,149,345

Previous 2,011,016 6.88%

Holding current value

$60.2 Million

Previous $57.9 Million 3.02%

% of portfolio

0.27%

Previous 0.28%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $3.58 Million - $4.11 Million	138,329 Added 6.88%	2,149,345 $59.6 Million
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $309,980 - $402,630	11,863 Added 0.59%	2,011,016 $57.9 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $2.51 Million - $2.93 Million	-78,140 Reduced 3.76%	1,999,153 $66.3 Million
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $3.89 Million - $4.5 Million	-107,595 Reduced 4.92%	2,077,293 $76.2 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $3.63 Million - $4.73 Million	-92,248 Reduced 4.05%	2,184,888 $89.1 Million

Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $109,259 - $142,626	-2,617 Reduced 0.11%	2,277,136 $117 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $168,300 - $205,453	-3,846 Reduced 0.17%	2,279,753 $99.8 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $316,171 - $374,880	-6,795 Reduced 0.3%	2,283,599 $120 Million
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $473,009 - $586,117	10,339 Added 0.45%	2,290,394 $119 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $936,476 - $1.39 Million	22,664 Added 1.0%	2,280,055 $135 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $5.26 Million - $6.75 Million	-133,942 Reduced 5.6%	2,257,391 $97.1 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $1.98 Million - $2.24 Million	-55,044 Reduced 2.25%	2,391,333 $93.6 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $2.03 Million - $2.29 Million	-60,669 Reduced 2.42%	2,446,377 $88.6 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $2.06 Million - $2.62 Million	-61,453 Reduced 2.39%	2,507,046 $92.3 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $601,472 - $705,664	18,944 Added 0.74%	2,568,499 $94.3 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $13.2 Million - $16 Million	-438,255 Reduced 14.67%	2,549,555 $83.4 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $2.22 Million - $3.17 Million	82,073 Added 2.82%	2,987,810 $97.5 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $48,161 - $54,657	-1,463 Reduced 0.05%	2,905,737 $114 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $158,161 - $205,088	4,868 Added 0.17%	2,907,200 $104 Million
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $912,703 - $1.02 Million	-24,681 Reduced 0.84%	2,902,332 $126 Million
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $1.33 Million - $1.47 Million	-35,596 Reduced 1.2%	2,927,013 $124 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $600,785 - $684,961	-15,617 Reduced 0.52%	2,962,609 $129 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $3.19 Million - $3.86 Million	-92,412 Reduced 3.01%	2,978,226 $131 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $4.93 Million - $5.25 Million	-149,458 Reduced 4.64%	3,070,638 $111 Million
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $11,774 - $13,660	-369 Reduced 0.01%	3,220,096 $114 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $14.4 Million - $15.3 Million	432,474 Added 15.51%	3,220,465 $117 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $86.4 Million - $95.2 Million	2,787,991	2,787,991 $99.5 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.

Account

King Luther Capital Management Corp Pfizer Inc Transaction History